Le’s Group injects new vitality into the development of the TCM medical service sector on the Hong Kong stock market. It will draw more investors’ attention to investment opportunities within the TCM medical space, and serve as a reference and model for other TCM medical service enterprises seeking listing. The Group strives to revitalize the TCM industry, restore the true essence of Chinese herbal medicine, leverage Eastern wisdom to advance global wellness, integrate tradition with modernity, fully unlock the medical value of TCM, and provide solid safeguards for national health.

Following ancient practices and adapting to modern ailments, Le’s Pharmaceuticals explores the root causes of illnesses. It revives the essence of the traditional TCM principle of individual prescriptions for each patient. Drawing on the ancestral secret formulas of the Le family, it brings healing and wellness recipes once reserved for imperial kinsfolk to ordinary people. Upholding the origins of TCM and carrying forward the tenet “Cultivate benevolence together; heal and nurture lives”, it enables TCM to shine brightly once more within the modern medical landscape.

Le’s selects only authentic medicinal herbs. It searches across the country for herb origins and abides by the ancestral precept: “Follow the teachings of Zhouhou and distinguish herbal provenance”. It ensures harvesting ages meet both Le’s quality standards and the requirements of the Chinese Pharmacopoeia. Herbs are gathered at the optimal season to deliver their maximum therapeutic efficacy.